BACKGROUND: Deep learning (DL) models are effective pre-screening tools for detecting mismatch repair deficiency (dMMR) in colorectal carcinoma (CRC). These models have been trained and validated on large cohorts from the Northern Hemisphere, without...
Randomized controlled trials (RCTs) have confirmed the mortality benefits of screening mammography and are the gold standard for evaluating new diagnostic tests and medical interventions. Reliable and rigorous execution of RCTs can be complex and req...
BACKGROUND AND AIMS: Coronary thin-cap fibroatheromas (TCFA) are associated with adverse outcome, but identification of TCFA requires expertise and is highly time-demanding. This study evaluated the utility of artificial intelligence (AI) for TCFA id...
BACKGROUND AND AIMS: Cardiovascular ageing is a progressive loss of physiological reserve, modified by environmental and genetic risk factors, that contributes to multi-morbidity due to accumulated damage across diverse cell types, tissues, and organ...
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
Dec 5, 2025
Early detection of uterine diseases is critically important for women's reproductive health. Here, we propose a novel and robust serum-based SERS analysis platform that integrates machine learning algorithms. This is the first application of it in th...
Multiple sclerosis (MS) is a highly heterogeneous disease in its clinical manifestation and progression. Predicting individual disease courses is key for aligning treatments with underlying pathobiology. We developed an unsupervised machine learning ...
Anti-seizure medications (ASMs) are often prescribed using a trial-and-error approach with a similar sequence for many patients. Comparative effectiveness data beyond the first ASM prescription are limited. Artificial intelligence can automatically e...
AJNR. American journal of neuroradiology
Dec 4, 2025
BACKGROUND AND PURPOSE: Distinguishing GM from WM is essential for CT of the brain. The recently established photon-counting detector (PCD)-CT technology uses a novel detection technique that might allow more precise measurement of tissue attenuation...
AJNR. American journal of neuroradiology
Dec 4, 2025
BACKGROUND AND PURPOSE: Identifying amyloid-beta (Aβ)-positive patients is essential for Alzheimer disease clinical trials and disease-modifying treatments but currently requires PET or CSF sampling. Previous MRI-based deep learning models using only...
Join thousands of healthcare professionals staying informed about the latest AI breakthroughs in medicine. Get curated insights delivered to your inbox.